Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB vs ROFECOXIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB vs ROFECOXIB: Safety Overview

Metric RITUXIMAB ROFECOXIB
Total FAERS Reports 178,614 1,238
Deaths Reported 28,910 56
Death Rate 16.2% 4.5%
Hospitalizations 54,631 176
Average Patient Age 54.6 yrs 63.1 yrs
% Female Patients 64.3% 77.9%
FDA Approval Date N/A Feb 25, 2000
Manufacturer Genentech, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Discontinued